Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Cancer Nursing|December 1, 1994
Safe handling of antineoplastic drugs. Results of a surveyR M Nieweg, M de Boer, R C Dubbleman, et al.
Oncology|July 1, 1993
A double-blind randomized crossover study to compare the antiemetic efficacy of 250 mg with 500 mg methylprednisolone succinate (Solu-Medrol) as a single intravenous dose in patients treated with noncisplatin chemotherapyR C Pieters, J B Vermorken, H E Gall, et al.
Plos One|June 8, 2010
alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic populationWalter E Gall, Kirk Beebe, Kay A Lawton, et al.
Environmental Science & Technology|November 23, 2012
Assessing impacts of land-applied manure from concentrated animal feeding operations on fish populations and communitiesJessica K Leet, Linda S Lee, Heather E Gall, et al.
Lancet (London, England)|February 9, 1999
Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trialJ B Vermorken, A M Claessen, H van Tinteren, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 19, 2000
Skin tests predict survival after autologous tumor cell vaccination in metastatic melanoma: experience in 81 patientsA Baars, A M Claessen, A J van den Eertwegh, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2006
Phase I trial with BMS-275183, a novel oral taxane with promising antitumor activityLinda E Bröker, Filip Y F L de Vos, Cees J van Groeningen, et al.
Cell|May 20, 2009
Protein architecture of the human kinetochore microtubule attachment siteXiaohu Wan, Ryan P O'Quinn, Heather L Pierce, et al.
Plos One|November 19, 2010
Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological settingKarsten Suhre, Christa Meisinger, Angela Döring, et al.
British Journal of Cancer|April 16, 2002
A phase II study of active specific immunotherapy and 5-FU/Leucovorin as adjuvant therapy for stage III colon carcinomaA Baars, A M E Claessen, J Wagstaff, et al.
Pageof 9